Philips Announces Q1 Results Aligned with 2024 Plan, Settles Respironi
- Cardio
- 29/04/2024
Philips Announces Q1 Results Aligned with 2024 Plan, Settles Respironics Litigation for $1.1 Billion
READ MOREPhilips Announces Q1 Results Aligned with 2024 Plan, Settles Respironics Litigation for $1.1 Billion
READ MOREUnited Imaging Healthcare Releases 2023 ESG Report, Advancing Mission of Equal Healthcare for All™
READ MORECERENOVUS Launches Next Generation Catheter to Treat Acute Ischemic Stroke in Europe
READ MOREAvicenna.AI Secures FDA Clearance For Two Healthcare AI Solutions
READ MOREGilgamesh Pharma Wins $14M Grant to Develop Safer Ibogaine for Opioid Disorder
READ MOREAidoc and ACC Collaborate to Revolutionize Cardiovascular Care with Best-in-Class AI
READ MOREVentripoint Showcases A.I.-Powered Heart-Scanning Technology at International Cardiology Conference
READ MOREAbu Dhabi Health Dept Names SKMC as Pediatric Cardiac Excellence Center
READ MOREToku Obtains CE and UKCA Marks for AI Cardiovascular Risk Assessments Through the Eye
READ MORENew Philips Mini TEE Ultrasound Transducer Helps Improve Cardiac Care for More Patients
READ MORE